Allspring Global Investments
KNSA icon

Allspring Global Investments’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Allspring Global Investments’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.16M Buy
65,097
+49,741
+324% +$2.58M 0.01% 924
2026
Q1 		$739K Buy
15,356
+1,584
+12% +$70.2K ﹤0.01% 1268
2025
Q4 		$568K Sell
13,772
-4,984
-27% -$200K ﹤0.01% 1341
2025
Q3 		$728K Sell
18,756
-185
-1% -$6.01K ﹤0.01% 1247
2025
Q2 		$524K Sell
18,941
-29,796
-61% -$758K ﹤0.01% 1329
2025
Q1 		$1.08M Sell
48,737
-572
-1% -$11.8K ﹤0.01% 1234
2024
Q4 		$975K Sell
49,309
-8,318
-14% -$190K ﹤0.01% 1310
2024
Q3 		$1.44M Sell
57,627
-7,316
-11% -$178K ﹤0.01% 1244
2024
Q2 		$1.21M Buy
64,943
+3,837
+6% +$71.9K ﹤0.01% 1295
2024
Q1 		$1.21M Buy
61,106
+9,490
+18% +$185K ﹤0.01% 1316
2023
Q4 		$905K Sell
51,616
-9,916
-16% -$163K ﹤0.01% 1362
2023
Q3 		$1.07M Sell
61,532
-305,443
-83% -$5.15M ﹤0.01% 1350
2023
Q2 		$5.17M Buy
366,975
+219,302
+149% +$2.94M 0.01% 988
2023
Q1 		$1.59M Sell
147,673
-67,446
-31% -$889K ﹤0.01% 1318
2022
Q4 		$3.22M Buy
215,119
+193,404
+891% +$2.82M 0.01% 1108
2022
Q3 		$278K Buy
21,715
+79
+0.4% +$900 ﹤0.01% 1724
2022
Q2 		$209K Sell
21,636
-222
-1% -$2.07K ﹤0.01% 1803
2022
Q1 		$217K Sell
21,858
-268
-1% -$2.84K ﹤0.01% 2547
2021
Q4 		$260K Buy
+22,126
New +$272K ﹤0.01% 2558

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Allspring Global Investments's KNSA Position: Q2 2026 in Review

Allspring Global Investments increased its Kiniksa Pharmaceuticals (KNSA) stake by 324% in Q2 2026, buying an estimated $2.58M and bringing the position to 65,097 shares worth $4.16M. The position accounts for 0.01% of the portfolio, ranked #924.

Allspring Global Investments first reported a position in KNSA in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.17M in Q2 2023. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Allspring Global Investments held 65,097 shares of Kiniksa Pharmaceuticals worth $4.16M as of Q2 2026.
  • Allspring Global Investments bought 49,741 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $2.58M.
  • Kiniksa Pharmaceuticals made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #924 holding.
  • Allspring Global Investments first reported a position in Kiniksa Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Kiniksa Pharmaceuticals position peaked at $5.17M in Q2 2023.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.